Investing.com - Stem (NYSE: STEM) reported third quarter EPS of $-0.910, $0.72 worse than the analyst estimate of $-0.190. Revenue for the quarter came in at $29.3M versus the consensus estimate of $56.8M.
Guidance
Stem sees FY 2024 revenue of $135.000M-$155.000M versus the analyst consensus of $222.600M.
Stem's stock price closed at $0.48. It is down -54.100% in the last 3 months and down -85.740% in the last 12 months.
Stem saw 0 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Stem's stock price’s past reactions to earnings here.
According to InvestingPro, Stem's Financial Health score is "weak performance".
Check out Stem's recent earnings performance, and Stem's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar